CAN ALPHA-FETOPROTEIN PREDICT POST LIVER TRANSPLANT HEPATOCELLULAR CARCINOMA RECURRENCE? A SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Kashkoush, Samy [1 ]
Almarastani, Mohamad [1 ]
Ohali, Wael [1 ]
Abdullah, Khalid [1 ]
机构：
[1] King Fahad Natl Guard Hosp, Riyadh, Saudi Arabia
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P065
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [41] On treatment alpha-fetoprotein reductions predict immunotherapy efficiency in patients with hepatocellular carcinoma
    Scheiner, Bernhard
    Pomej, Katharina
    Balcar, Lorenz
    Meischl, Tobias
    Mueller, Christian
    Trauner, Michael
    Pinter, Matthias
    JOURNAL OF HEPATOLOGY, 2022, 77 : S919 - S919
  • [42] Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma
    Soresi, M
    Magliarisi, C
    Campagna, P
    Leto, G
    Bonfissuto, G
    Riili, A
    Carroccio, A
    Sesti, R
    Tripi, S
    Montalto, G
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1747 - 1753
  • [43] EXCESSIVE ALPHA-FETOPROTEIN CONCENTRATIONS IN HEPATOCELLULAR CARCINOMA
    AMERY, AH
    ALSTON, WC
    KOHN, J
    WHITE, WF
    BRITISH MEDICAL JOURNAL, 1977, 2 (6087): : 611 - 612
  • [44] Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
    Galle, Peter R.
    Foerster, Friedrich
    Kudo, Masatoshi
    Chan, Stephen L.
    Llovet, Josep M.
    Qin, Shukui
    Schelman, William R.
    Chintharlapalli, Sudhakar
    Abada, Paolo B.
    Sherman, Morris
    Zhu, Andrew X.
    LIVER INTERNATIONAL, 2019, 39 (12) : 2214 - 2229
  • [45] National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time
    Mehta, Neil
    Dodge, Jennifer L.
    Grab, Joshua D.
    Yao, Francis Y.
    HEPATOLOGY, 2020, 71 (03) : 943 - 954
  • [46] Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?
    Kudo, Atsushi
    Matsumura, Satoshi
    Ban, Daisuke
    Irie, Takumi
    Ochiai, Takanori
    Tanaka, Shinji
    Arii, Shigeki
    Tanabe, Minoru
    HEPATOLOGY RESEARCH, 2014, 44 (14) : E437 - E446
  • [47] Serum alpha-fetoprotein level can improve eligibility criteria for liver transplantation in patients with hepatocellular carcinoma
    Ioannou, George
    Berry, Kristin
    HEPATOLOGY, 2012, 56 : 240A - 241A
  • [48] Preoperative Alpha-Fetoprotein and Radiological Total Tumor Diameter as Predictors of Hepatocellular Carcinoma Recurrence After Liver Transplantation
    Galdino-Vasconcelos, Mayara Regina
    Feijo, Mateus Silva
    Ferro, Henrique Metzker
    Ramalho Gomes, Ana Clara
    De Almeida Santos, Maria Eduarda
    Ferreira, Gustavo
    Jorge, Fernando
    Trevizoli, Natalia
    Diaz, Luiz Gustavo
    De Campos, Priscila Brizolla
    Caja, Gabriel
    Ullmann, Raquel
    Figueira, Ana Virginia
    Morato, Tiago
    Conde Watanabe, Andre Luis
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (05) : 1333 - 1340
  • [49] Closely monitored alpha-fetoprotein allows early detection of hepatocellular carcinoma recurrence after orthotopic liver transplantation
    Hahn, Magdalena
    Herber, Adam
    Al-Sayegh, Rami
    Fischer, Janett
    Olbrich, Anne
    Rademacher, Sebastian
    Seehofer, Daniel
    Ebel, Sebastian
    Denecke, Timm
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2022, 77 : S931 - S932
  • [50] INCREASED ALPHA-FETOPROTEIN AFTER BRIDGE THERAPIES AS PREDICTOR OF RECURRENCE IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH LIVER TRANSPLANTATION
    Lai, Quirino
    Avolio, Alfonso W.
    Manzia, Tommaso M.
    Agnes, Salvatore
    Tisone, Giuseppe
    Berloco, Pasquale B.
    Rossi, Massimo
    TRANSPLANT INTERNATIONAL, 2011, 24 : 3 - 3
12345